ConductScience.org, home

Trial · NCT02361944

Registered outcomes33

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryIntraoperative Systemic Oxidative Damageseparation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention)quantified by measuring F2-isoprostanes isofurans following separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting
PrimaryAcute Kidney Injurybaseline to postoperative day 2quantified by change in serum creatinine concentration
SecondaryVascular Reactivity / Endothelial Function (as Measured by Flow Mediated Dilation)ICU admission (immediately after arrival in ICU from operating room)
brachial artery flow mediated dilation assessed when patient arrives in ICU after surgery. brachial artery flow mediated dilation is represented as the percent change in brachial artery diameter following 5 minutes of artery occlusion. The entire assessment takes place at ICU admission.
SecondaryMitochondrial Functionup to 2 days following surgerymitochondrial function in atrial myocardium estimated by quantifying adenylate kinase at the end of surgery and oxygen intervention
SecondaryNumber of People With Arrhythmiafrom surgery to hospital discharge, average of 6 days following surgerydefined as any atrial fibrillation following surgery until hospital discharge assessed using continuous telemetry, rhythm strips, and electrocardiograms
SecondaryMyocardial Injury or Infarctionmorning of postoperative day 1plasma concentration of creatine kinase, myocardial band
SecondaryNumber of People With Strokefrom surgery to hospital discharge, average of 6 days following surgeryDefined as new deficit on neurologic exam and confirmed with radiologic evidence occurring at any point prior to hospital discharge
SecondaryPostoperative Cognitive Dysfunctionup to 18 months following surgery
Median change scores at the Short Blessed Scale (SBT) administered one-year following surgery. The SBT is a validated rating scale, administered by the clinician, measuring the cognitive performance. Sum Total (range 0-28) with 0 indicating no cognitive impairment and 28 indicating severe cognitive impairment.
SecondaryRespiratory Failurefrom surgery to hospital discharge, average of 6 days following surgeryreintubation
SecondaryChronic Kidney Disease12 months following surgeryeGFR one year following surgery
SecondaryInflammationup to 2 days following surgeryEstimated by quantifying plasma concentration of plasminogen activator inhibitor-1 (PAI-1)
SecondaryHemolysisseparation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention)plasma free hemoglobin
SecondaryReactive Oxygen Species Productionend of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention)TMH electron spin probe
SecondaryAcute Brain Dysfunction (Delirium)from surgery to hospital discharge, average of 6 days following surgery
The number of participants with acute brain dysfunction as assessed by the Confusion Assessment Method for the ICU (CAM-ICU) twice daily while patients are in the ICU or for first 3 postoperative days.
SecondaryOxygenation and Perfusion (Lactate)ICU admission (immediately after arrival in ICU from operating room)arterial lactate measured from arterial blood collected at ICU admission (immediately after arrival in ICU from operating room)
SecondaryAcute Kidney Injury, According to KDIGO Criteriaup to 7 days following surgeryKDIGO acute kidney injury is defined as an increase in SCr ≥ 0.3 mg/dL (≥ 26.5 lmol/L) within 48 hours of surgery or 1.5 to 1.9 times baseline within 7 days of surgery
SecondaryAcute Kidney Injury Estimated by Urine Concentration of TIMP-2 IGFBP7baseline to 2 days following surgeryUrinary concentration of \[TIMP2\]\*\[IGFBP7\] 6 hours after ICU admission
SecondaryAcute Kidney Injury Estimated by Urine Concentration of NGALbaseline to 2 days following surgeryUrinary concentration of neutrophil gelatinase-associated lipocalin (NGAL) 6 hours after ICU admission.
SecondaryReactive Oxygen Species Productionend of surgery, defined as immediately after separation from cardiopulmonary bypass or completion of off-pump coronary artery bypass grafting (approximately 3-5 hours into surgery and intervention)CAT1H electron spin probe
SecondaryOxygenation and Perfusion (SpO2)during surgery
hemoglobin O2 saturation summarized using SpO2 data continuously measured and recorded every minute during surgery. We calculated the median SpO2 throughout surgery using all the minute to minute values. For example, if a participant had a 5 hour (300 minutes) long surgery, the participant would have 300 SpO2 measurements. We calculated and report the median of those measurements.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02361944/registered